Skip to Main Content

Paper Details

Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
J Immunother Cancer
21
2021
Author NameAffiliation
Dexiang GaoCancer Center Biostatistics Core, University of Colorado Anschutz Medical Campus
Antonio JimenoUniversity of Colorado Anschutz Medical Campus
  • 1 - 2

Datasets

Release 1.2